IRVINE, Calif., March 14 /PRNewswire-FirstCall/ -- Masimo Corporation
(Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motion &
Low Perfusion pulse oximetry, today announced that it is scheduled to present
at the Citi Investment Research 5th Annual Small & Mid-Cap Conference at The
Four Seasons Hotel in Las Vegas, NV on Wednesday, March 19, 2008 at 2:25 p.m.
PT. Joe E. Kiani, Chairman and CEO, and Mark P. de Raad, Executive Vice
President and CFO, will be presenting.
A live Web cast of the presentation will be available on the Masimo Web
site at http://www.masimo.com. A replay of the Web cast will be available
following the live presentation.
About Masimo: Masimo (NASDAQ: MASI) develops innovative monitoring
technologies that significantly improve patient care -- helping solve
"unsolvable" problems. In 1995, the company debuted Measure-Through Motion and
Low Perfusion pulse oximetry, known as Masimo SET, and with it virtually
eliminated false alarms and increased pulse oximetry's ability to detect
life-threatening events. More than 100 independent and objective studies
demonstrate Masimo SET provides the most trustworthy SpO2 and pulse rate
measurements even under the most difficult clinical conditions, including
patient motion and low peripheral perfusion. In 2005, Masimo introduced Masimo
Rainbow SET, a breakthrough noninvasive blood constituent monitoring platform
that can measure many blood constituents that previously required invasive
procedures. Rainbow SET continuously and noninvasively measures total
hemoglobin (SpHb(TM)) and oxygen content (SpOC(TM)) (pending FDA clearance),
carboxyhemoglobin (SpCO(R)), methemoglobin (SpMet(R)), and pleth variability
index (PVI(TM)), in addition to oxyhemoglobin (SpO2), perfusion index (PI) and
pulse rate, allowing early detection and treatment of potentially
life-threatening conditions. Founded in 1989, Masimo has the mission of
"Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive
Monitoring to New Sites and Applications." Additional information about Masimo
and its products may be found at http://www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing
Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications,
Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Pulse CO-Oximetry and Pulse CO-Oximeter
are trademarks or registered trademarks of Masimo Corporation.
SOURCE Masimo Corporation
CONTACT: Investors, Mark P. de Raad, Executive Vice President and Chief
Financial Officer, +1-949-297-7080, mderaad@masimo.com, or Media, Dana Banks,
Manager, Public Relations, +1-949-297-7348, dbanks@masimo.com, both of Masimo
Corporation
Web site: http://www.masimo.com